Functional Assessment of Ashwagandaha Root Extract During Weight Loss
Last updated on July 2021Recruitment
- Recruitment Status
- Recruiting
- Estimated Enrollment
- Same as current
Summary
- Conditions
- Craving
- Obesity
- Sleep Disturbance
- Stress Reaction
- Type
- Interventional
- Phase
- Phase 3
- Design
- Allocation: RandomizedIntervention Model: Parallel AssignmentIntervention Model Description: If the PSS score is than 20, those patients who are interested in participating are consented to the Ashwagandha study. The patients will then be randomized in a double-blind fashion to receive a 31 day supply of study capsules which will be either Ashwagandha 300mg twice a day or identical placebo capsules in a 1:1 ratio. They will be given careful directions into the use of the study capsules and will be asked to mark a daily log (See addendum #3: Treatment Log) of taking the capsules in the morning and at night.Masking: Triple (Participant, Care Provider, Investigator)Masking Description: A designated MD who is not involved in the study design, application, or interpretation will be available to unblind study participants when medically indicatedPrimary Purpose: Treatment
Participation Requirements
- Age
- Between 18 years and 70 years
- Gender
- Both males and females
Description
During this 12-week medical weight loss program, the randomized patients will also have a baseline measurements and final measurements of blood for selected adipokines , cytokines, and telomerase measurements
During this 12-week medical weight loss program, the randomized patients will also have a baseline measurements and final measurements of blood for selected adipokines , cytokines, and telomerase measurements
Tracking Information
- NCT #
- NCT03112824
- Collaborators
- Not Provided
- Investigators
- Principal Investigator: Warren R Peters, MD MPH LLU Administrator
Get Well Soon